In line of this agreement, we detected reduced protein levels of CD79b (Supplementary Figure 3) but increased expression of CD79a in CLL cells from majority of previously untreated CLL patients. This evidence concerns the gene CD79A and B-cell chronic lymphocytic leukemia.